IRS-1 mediates IGF-1-dependent growth in these cells, which has also been observed for hepatocellular and prostate carcinoma, medulloblastoma and malignant pleural mesothelioma cell lines [37,66-70]. Here, IRS1 is linked to prostate carcinoma.